Published Paper Details:

Cervical cancer is a significant worldwide health concern. With the intention of advising medical professionals and researchers on current advancements and potential future paths in this area, this comprehensive analysis provides an overview of the available and developing cervical cancer therapy options. Surgical techniques, radiation therapy, and chemotherapy are the current treatment options for cervical cancer; they are often used in combination, depending on the disease's stage and severity. However, in situations that are advanced or recurrent, these traditional therapies may not be effective and are often associated with serious adverse effects. As a result, the need for creative treatment approaches is rising. Recent developments in cervical cancer treatment include a variety of cutting-edge strategies including gene-based therapy, immunotherapy, and targeted therapy. Clinical trials have shown promising outcomes for targeted medicines, such as those that inhibit Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR), particularly when paired with conventional medications. Immunotherapy has revolutionized cancer treatment and has great potential for people with cervical cancer, especially when it comes to immune checkpoint inhibitors. Furthermore, gene therapy approaches that involve gene editing and oncolytic viruses provide novel ways to eradicate cancer cells while protecting healthy tissue. Patient outcomes for cervical cancer might be significantly improved in the next years by incorporating these novel medicines into routine medical care. To address medication resistance concerns, find predictive biomarkers for patient selection, and enhance treatment regimens, further study is required. In order to get these new treatments from lab research to clinical practice and eventually lessen the global effect of cervical cancer, partnerships between medical professionals, academics, and the pharmaceutical industry will be essential.